ArticleOncotarget2015

Reciprocal feedback inhibition of the androgen receptor and PI3K as a novel therapy for castrate-sensitive and -resistant prostate cancer.

Wenqing Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.